About
About Us
Leadership
Scientific Advisory Board
Locations
Development History
Awards
Investor
Announcements
Stock Trend
Investor Interaction
ESG
ESG
ESG Concept
ESG Policy
Media Center
Video Center
Image Center
Product & Services
API & Intermediate
Portfolio
R&D
Patents
CDMO
One-Stop Service
Platforms
Capacity
Finished Dosage Form
Product Service
R&D
Aesthetic & Care Ingredients
Portfolio
R&D
Technology Platforms
DS Technology Platforms
Flow Chemistry
Synthetic Biology & Biocatalysis
Crystallization & Particle Engineering
Peptide
High Potency Compound
Conjugate Library Service
Oligonucleotide Synthesis
Preparation & Purification
DP Technology Platforms
Controlled-release Formulation Development
Taste Masking Technology
Particle Flow Simulation
Technical Support Centers
Analytical Testing Center
Process Safety Center
News
Events
News Room
Careers
Join Us
Meet our People
Talent Strategy
Working at Apeloa
CN
Contact Us
About
About Us
Leadership
Scientific Advisory Board
Locations
Development History
Awards
Investor
Announcements
Stock Trend
Investor Interaction
ESG
ESG
ESG Concept
ESG Policy
Media Center
Video Center
Image Center
Product & Services
API & Intermediate
Portfolio
R&D
Patents
CDMO
One-Stop Service
Platforms
Capacity
Finished Dosage Form
Product Service
R&D
Aesthetic & Care Ingredients
Portfolio
R&D
Technology Platforms
DS Technology Platforms
Flow Chemistry
Synthetic Biology & Biocatalysis
Crystallization & Particle Engineering
Peptide
High Potency Compound
Conjugate Library Service
Oligonucleotide Synthesis
Preparation & Purification
DP Technology Platforms
Controlled-release Formulation Development
Taste Masking Technology
Particle Flow Simulation
Technical Support Centers
Analytical Testing Center
Process Safety Center
News
Events
News Room
Careers
Join Us
Meet our People
Talent Strategy
Talent Development
Talent Policy
Working at Apeloa
Contact Us
CN
【公示】浙江普洛得邦制药有限公司无菌项目先行验收固体废物调查报告
author：
Aperoa
2020.Nov.05
年产225吨头孢菌素原料药和年产620吨头孢类、110吨青霉素类无菌原料药GMP生产线建设项目（一期工程固体废物）环境保护验收公示材料如下：
相关附件如下：
公示文件
Previous：
none
Next：
none
Back to list
We value your privacy
To enhance user experience and protect your rights and privacy, please review our
Privacy Policy
and
Legal Statement
. By clicking "Accept All", you acknowledge and accept the above terms.
Reject All
Accept All
